Details for 2017807519

Up to date per 03.04.2026

Actions

Title / Product Name

VERBINDUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017807519

EP Publication Number

3464336

E-Number

1475822

Language

PCT Number

US17035547

Publication Date

10.04.2019 A

16.03.2022 B1

Registration Date

16.03.2022

AT Publication Date

15.04.2022

Application Date

01.06.2017

Registration Number

Priorities

01.06.2016

201662344305 P

IPC

C07K 5/065 20060101AFI20191211BHEP

Maximum Duration of Protection

01.06.2037

Owner

Athira Pharma, Inc.18706 North Creek Parkway, Suite 104 Bothell, WA 98011US

Representative

Paul CosmoviciGumpendorfer Straße 1421060 WienAT

Inventor

KAWAS, Leen, H.c/o M3 Biotechnology Inc. 4000 Mason Road Suite 300 Box 352141 Seattle WA 98195US

SINGH, Jasbirc/o M3 Biotechnology Inc. 4000 Mason Road Suite 300 Box 352141 Seattle WA 98195US

STEWART, Lansing Josephc/o M3 Biotechnology Inc. 4000 Mason Road Suite 300 Box 352141 Seattle WA 98195US

BAKER, William, R.c/o M3 Biotechnology Inc. 4000 Mason Road Suite 300 Box 352141 Seattle WA 98195US

Information about Fees